Contribution of the renin‐angiotensin system to short‐term blood pressure variability during blockade of nitric oxide synthesis in the rat

Open Access
Publisher Website
Google Scholar
Abstract
1 The aim of this study was to investigate, by use of spectral analysis, (1) the blood pressure (BP) variability changes in the conscious rat during blockade of nitric oxide (NO) synthesis by the L-arginine analogue NG-nitro-L-arginine methyl ester (L-NAME); (2) the involvement of the renin-angiotensin system in these modifications, by use of the angiotensin II AT1-receptor antagonist losartan. 2 Blockade of NO synthesis was achieved by infusion for 1 h of a low-dose (10 μg kg−1 min−1, i.v., n = 10) and high-dose (100 μg kg−1 min−1, i.v., n = 10) of L-NAME. The same treatment was applied in two further groups (2 × n = 10) after a bolus dose of losartan (10 mg kg−1, i.v.). 3 Thirty minutes after the start of the infusion of low-dose L-NAME, systolic BP (SBP) increased (+ 10 ± 3 mmHg, P < 0.01), with the effect being more pronounced 5 min after the end of L-NAME administration (+ 20 ± 4 mmHg, P < 0.001). With high-dose L-NAME, SBP increased immediately (5 min: + 8 ± 2 mmHg, P < 0.05) and reached a maximum after 40 min (+ 53 ± 4 mmHg, P < 0.001); a bradycardia was observed (60 min: −44 ± 13 beats min−1, P < 0.01). 4 Low-dose L-NAME increased the low-frequency component (LF: 0.02-0.2 Hz) of SBP variability (50 min: 6.7 ± 1.7 mmHg2 vs 3.4 ± 0.5 mmHg2, P < 0.05), whereas the high dose of L-NAME not only increased the LF component (40 min: 11.7 ± 2 mmHg2 vs 2.7 ± 0.5 mmHg2, P < 0.001) but also decreased the mid frequency (MF: 0.2-0.6 Hz) component (60 min: 1.14 ± 0.3 mmHg2 vs 1.7 ± 0.1 mmHg2, P < 0.05) of SBP. 5 Losartan did not modify BP levels but had a tachycardic effect (+ 45 beats min−1). Moreover, losartan increased MF oscillations of SBP (4.26 ± 0.49 mmHg2 vs 2.43 ± 0.25 mmHg2, P < 0.001), prevented the BP rise provoked by the low-dose of L-NAME and delayed the BP rise provoked by the high-dose of L-NAME. Losartan also prevented the amplification of the LF oscillations of SBP induced by L-NAME; the decrease of the MF oscillations of SBP induced by L-NAME was reinforced after losartan. 6 We conclude that the renin-angiotensin system is involved in the increase in variability of SBP in the LF range which resulted from the withdrawal of the vasodilating influence of NO. We propose that NO may counterbalance LF oscillations provoked by the activity of the renin-angiotensin system.